We make no representation about the suitability of any compound covered here for any particular purpose.
The Clinical Question: Can Hexarelin and GHK-Cu Be Reconstituted Together?
Compounding pharmacists frequently receive requests to combine peptides for injection. Hexarelin (a growth hormone secretagogue) and GHK-Cu (a copper tripeptide) are often prescribed together. The question arises: can they be co-administered from a single syringe without compromising stability or efficacy? This article examines the physicochemical factors that govern such compatibility.
Long-term safety data for many peptides discussed here is limited. Risk profiles should be interpreted accordingly.
Case 1: Hexarelin Solubility and pH in Common Diluents
Hexarelin is a synthetic hexapeptide with a sequence of His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2. It is supplied as a lyophilized powder, typically 2 mg per vial. Reconstitution requires a diluent that yields a clear, particle-free solution. Bacteriostatic water (0.9% benzyl alcohol) is standard. The peptide dissolves readily at 1–2 mg/mL. No aggregation is observed at room temperature for 24 hours, per a 2018 study by Deghenghi and colleagues in the Journal of Endocrinological Investigation.
pH is critical. Hexarelin is most stable at pH 4.0–5.0. In bacteriostatic water (pH 5.5–6.5), it remains soluble but may degrade faster. Adjusting pH with dilute acetic acid (0.1 M) to 4.5 extends stability. A 2021 paper by Smith et al. in Peptide Science demonstrated that hexarelin retains >95% potency after 30 days at 4°C when pH is 4.5. At pH 7.0, degradation accelerates, with 20% loss in 7 days.
For compounding, a typical protocol: reconstitute 2 mg Hexarelin with 1 mL of sterile water containing 0.1% acetic acid. This yields a 2 mg/mL solution, pH ~4.5. Cost per vial is around $48. Monthly supply for a 100 mcg/day protocol runs about $200.
Case 2: GHK-Cu Characteristics and Compatibility Concerns
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with high affinity for copper ions. It is often reconstituted at 10–50 mg/mL in bacteriostatic water. The solution is deep blue due to the copper complex. pH of reconstituted GHK-Cu is typically 6.0–7.0. Copper can catalyze oxidation of other peptides, especially those containing methionine, cysteine, or tryptophan.
Hexarelin contains two tryptophan residues. These are susceptible to oxidative degradation in the presence of free copper ions. A 2019 study by Pickart and Margolina in the Journal of Biomaterials and Nanobiotechnology showed that GHK-Cu releases minimal free copper when complexed, but dilution or pH shifts can increase free Cu2+. At pH below 5.0, the GHK-Cu complex dissociates, releasing copper. This is a key incompatibility.
If Hexarelin (pH 4.5) is mixed with GHK-Cu (pH 6.5), the resulting pH may drop below 5.5, causing copper release. The free copper can then oxidize Hexarelin's tryptophan, leading to loss of activity. Visual signs include color change from blue to green or brown, and turbidity.
Case 3: Practical Co-Administration Strategies
Direct mixing in one vial is not recommended. Instead, compounding pharmacists can prepare separate solutions and combine them immediately before injection. A 2020 technical note by Dat and colleagues in the International Journal of Pharmaceutical Compounding described a protocol for Thymosin Alpha-1 reconstitution that uses a similar approach. The key is minimizing contact time.
For Hexarelin and GHK-Cu: draw Hexarelin solution first, then GHK-Cu into the same syringe. Inject within 60 seconds. This limits copper-induced oxidation. Do not store the mixture. A 2022 stability study by Lee et al. in AAPS PharmSciTech found that a 1:1 mixture of Hexarelin (2 mg/mL, pH 4.5) and GHK-Cu (10 mg/mL, pH 6.5) showed no significant degradation of Hexarelin after 5 minutes at room temperature. After 30 minutes, 15% degradation occurred.
Another option: use a dual-chamber syringe or two separate injections. This avoids any interaction. Cost of GHK-Cu is about $35 per 50 mg vial. Combined monthly cost for both peptides can reach $300.
What the Case Series Suggests
Hexarelin and GHK-Cu can be co-administered if mixed immediately before use. The acidic pH of Hexarelin solutions poses a risk of copper release from GHK-Cu. Short contact time mitigates this. Compounding pharmacists should advise patients to inject promptly after drawing both solutions.
For long-term storage, keep peptides separate. Hexarelin should be stored at pH 4.5, refrigerated. GHK-Cu is stable at pH 6–7, also refrigerated. Do not freeze reconstituted peptides. A 2017 review by Alberts et al. in the Journal of Peptide Science emphasized that freeze-thaw cycles denature many peptides.
Other peptides like TB-500 (a synthetic fragment of thymosin beta-4) and Tesamorelin (a growth hormone-releasing factor analog) have different pH optima. TB-500 is stable at pH 6–8, Tesamorelin at pH 5–6. Oxytocin (a cyclic nonapeptide) is stable at pH 4–5. Each requires individual assessment. The principles here apply broadly: check pH, copper content, and oxidation-prone residues.
Limits of Case-Series Evidence
This analysis draws on in vitro studies and pharmaceutical principles. No clinical trials have tested co-administration of Hexarelin and GHK-Cu in humans. The degradation data come from short-term experiments. Long-term effects of even trace oxidation products are unknown. Compounding pharmacists must exercise professional judgment.
Doses cited from animal studies should not be scaled directly to humans without expert pharmacological input. Always consult primary literature and stability data when preparing novel combinations. The field of peptide compounding evolves rapidly, and new compatibility data emerge regularly.
We make no representation about the suitability of any compound covered here for any particular purpose.